Prognostic and clinicopathological value of high expression of TIM ‐3 in different cancer types: A meta‐analysis
Precision Medical Sciences · 2020
DOI: 10.1002/prm2.12007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Medical Sciences, 2020. Verfasst von Wenbo Xu und 7 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This meta‐analysis was performed to clarify the prognostic role of the expression of T‐cell immunoglobulin mucin‐3 (TIM‐3) in different cancer types.
Methods
Related articles were searched from PubMed, EMBASE, Web of Science up to December 31, 2019. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were utilized to explore their associations. In addition, we conducted subgroup analyses stratified by various factors.
Results
Eventually, a total of 33 studies including 4223 patients were enrolled in this study. Results showed that patients with high TIM‐3 expression had shorter overall survival (OS) (HR = 1.67, 95% CI: 1.37‐2.04) and progression‐free survival (HR = 1.80, 95% CI: 1.14‐2.83), but subgroup analyses indicated there were no relationship between TIM‐3 expression and disease‐free survival or recurrence‐free survival. It was reassuring that high TIM‐3 expression may be associated with poor prognosis in osteosarcoma, gastric cancer, liver cancer, esophageal cancer, and lymphoma, while no prognostic significance was detected of TIM‐3 expression in lung cancer, kidney cancer, or breast cancer. Furthermore, we did not find association of TIM‐3 with any clinicopathological parameters.
Conclusions
High TIM‐3 expression might be a potential biomarker which can be used to predict the poor prognosis of different cancer types, especially osteosarcoma, gastric cancer, liver cancer, esophageal cancer, and lymphoma.
Zitieren
APA
Xu, W., Qi, F., Jiao, R., Zheng, L., Zhang, Y., Hou, D., Liu, Y., & Kang, Z. (2020). Prognostic and clinicopathological value of high expression of TIM ‐3 in different cancer types: A meta‐analysis. Precision Medical Sciences. https://doi.org/10.1002/prm2.12007
Vancouver
Xu W, Qi F, Jiao R, Zheng L, Zhang Y, Hou D, et al. Prognostic and clinicopathological value of high expression of TIM ‐3 in different cancer types: A meta‐analysis. Precision Medical Sciences. 2020. doi:10.1002/prm2.12007
BibTeX
@article{Xu2020,
author = {Xu, Wenbo and Qi, Feng and Jiao, Ruidi and Zheng, Lizhuan and Zhang, Yinghao and Hou, Donghai and Liu, Yi and Kang, Zhengjun},
title = {Prognostic and clinicopathological value of high expression of TIM ‐3 in different cancer types: A meta‐analysis},
journal = {Precision Medical Sciences},
year = {2020},
doi = {10.1002/prm2.12007}
}
EUVIMED